Search database
LIST OPTIONS
Filter
62
Filtered Results: 62
Text search: DNDi - Drugs for neglected diseases initiative
Featured
Language
Document type
Studies & Reports
24
No document type
12
Strategic & Response Plan
6
Manuals
5
Resource Platforms
5
Guidelines
3
Videos
3
Fact sheets
3
Infographics
1
Countries / Regions
Global
8
Latin America and the Carribbean
5
Colombia
3
Kenya
2
Africa
2
West and Central Africa
2
East and Southern Africa
2
Ethiopia
2
Asia
1
Southern Africa
1
Uganda
1
Brazil
1
India
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
14
World Health Organization WHO
9
et al.
6
DNDi - Drugs for neglected diseases initiative
5
Forsyth, C.
4
Unitaid
4
World Health Organisation (WHO)
3
World Health Organization (WHO)
3
Dahal, P.
2
Drugs for Neglected Diseases initiative DNDi - Latin America
2
A.Hill, T. Swan and K.Timmermans
1
Aksoy, S.
1
Avaria, A. et al.
1
Barrett MP, Priotto G, Franco JR, et al.
1
Batista, C.
1
Bayão T.S., Cupertino M.C., Gomes A.P. et al
1
Bernal, O.
1
Bernal, OA
1
Bernhard, S.
1
Brindley, P. et al.
1
Brot für die Welt
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
Burri, C.
1
Caicedo Díaz, RA,
1
Chagas Coalition
1
Diseases
1
DNDi Latin America
1
Drugs for Neglected Diseases Initiative DNDi Latin America
1
Fanjul, G.
1
Federal Ministry of Health, Ethiopia
1
GARDP Global Acntibiotic Research & Dedvelopment Partnership
1
Global Health Alliance-Deutschland (GHA-D)
1
Herazo, F.
1
Hommes F, Stratil J, Ströbele L, Bruchhausen W
1
Hotez, P.
1
Journal of the Brazilian Society of Tropical Medicine
1
Kaiser, M.
1
Khan, J.
1
LEAP
1
Maguire, B.
1
Maguire, B.J.
1
Marchiol, A
1
Mäser, P.
1
McGloin, J.
1
Médecins Sans Frontières
1
Ministry of Health Ethiopia
1
Moriana, S.
1
MSF Access Campaign
1
Oritz, G.
1
Pan American Health Organization PAHO
1
Pan American Journal of Public Health
1
PLOS Neglected Tropical Diseases
1
Rashan, S.
1
Rashan, S. et al.
1
Sanmatino, M.
1
TB Alliance
1
Unicef
1
UNICEF, UNESCO, Asia Pacific Network of People living with HIV
1
Wamai, R.
1
World Health Organization (Western Pacific Region)
1
Zaidel, E.J.
1
Ziaggi, G.
1
Publication Years
Category
Studies & Reports
4
Guidelines
3
Hepatitis
2
Pediatrics
2
Statistics
2
COVID-19
1
Virology
1
Chagas
1
Medical Devices & Equipment
1
Drugs & Medical Equipment
1
NTDs & Others
1
Leishmaniasis
1
Human African Trypanosomiasis
1
Non-communicable Diseases
1
HIV & STI
1
Pharmacy & Technologies
1
Toolboxes
Studies & Reports
8
Strategies & Roadmaps
5
Studies & Reports
5
Capacity Building & Resources
4
Studies & Reports
4
Clinical Aspects & Diagnostics
3
Local Action
2
Essential Medicines
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
NTDs General
2
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Introduction to Global Health
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Children
1
Health Equity & Equality
1
Country specific documents
1
Long COVID/ Post-COVID Syndrome
1
Advocacy & Communication
1
Prices and Patents
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Overview, Studies & Reports
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Information & Education Material (IEC)
1
Asia and Pacific
1
Human Rights & the Right to Health
1
Antiretroviral Treatment ART
1
AMR
1
Reports & Studies
1
PLOS Neglected Tropical Diseases 18(5): e0012091. https://doi.org/10.1371/journal.pntd.0012091
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-... more
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand... more
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis... more
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions. Gr... more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi- nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim- i... more
Lessons from the STEP-TB Project. Accessed November 2017.
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Technology landscape
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ... more
Meeting Report 27–30 June 2017 Manila, Philippines
Rreport of a WHO Consultative Meeting Kolkata India 2012
Overcoming barriers in low- and middle-income countries For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha... more
The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58